367
Views
5
CrossRef citations to date
0
Altmetric
Review

Role of Mitochondrial DNA (mtDNA) Variations in Cancer Development: A Systematic Review

ORCID Icon, , &
Pages 375-393 | Received 21 Feb 2020, Accepted 15 Jul 2020, Published online: 29 Jul 2020

References

  • Anderson S, Bankier AT, Barrell BG, de Bruijn MH, Coulson AR, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature. 1981;290:457–465. doi:10.1038/290457a0.
  • Reguly B, Jakupciak JP, Parr RL. 3.4 kb mitochondrial genome deletion serves as a surrogate predictive biomarker for prostate cancer in histopathologically benign biopsy cores. CUAJ. 2010;4:E118–E122. doi:10.5489/cuaj.932.
  • Mercer TR, Neph S, Dinger ME, Crawford J, Smith MA, Shearwood AM, et al. The human mitochondrial transcriptome. Cell. 2011;146:645–658. doi:10.1016/j.cell.2011.06.051.
  • Scheffler IE, editor. Mitochondria. Hoboken (NJ): John Wiley & Sons; 2008.
  • Wallace DC. Mitochondria and cancer. Nat Rev Cancer. 2012;12:685–698. doi:10.1038/nrc3365.
  • Warburg O. On the origin of cancer cells. Science. 1956;123:309–314. doi:10.1126/science.123.3191.309.
  • Aisenberg AC, Potter VR. Studies on the Pasteur effect. II. Specific mechanisms. J BiolChem. 1957;224:1115–1127.
  • LeBleu VS, O'Connell JT, Gonzalez Herrera KN, Wikman H, Pantel K, Haigis Marcia C, et al. PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat Cell Biol. 2014;16:992–1003. doi:10.1038/ncb3039.
  • GLOBOCAN. 2018. The online database is accessible at http://gco.iarc.fr/, as part of IARC’s Global Cancer Observatory and https://www.wcrf.org/.
  • Setiawan VW, Chu LH, John EM, Ding YC, Ingles SA, Bernstein L, et al. Mitochondrial DNA G10398A variant is not associated with breast cancer in African-American women. Cancer Genet Cytogenet. 2008;181:16–19. doi:10.1016/j.cancergencyto.2007.10.019.
  • Darvishi K, Sharma S, Bhat AK, Rai E, Bamezai RN. Mitochondrial DNA G10398A polymorphism imparts maternal Haplogroup N a risk for breast and esophageal cancer. Cancer Lett. 2007;249:249–255. doi:10.1016/j.canlet.2006.09.005.
  • Canter JA, Kallianpur AR, Parl FF, Millikan RC. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res. 2005;65:8028–8033. doi:10.1158/0008-5472.CAN-05-1428.
  • Czarnecka AM, Krawczyk T, Zdrozny M, Lubiński J, Arnold RS, Kukwa W, et al. Mitochondrial NADH-dehydrogenase subunit 3 (ND3) polymorphism (A10398G) and sporadic breast cancer in Poland. Breast Cancer Res Treat. 2010;121:511–518. doi:10.1007/s10549-009-0358-5.
  • Fang H, Shen L, Chen T, He J, Ding Z, Wei J, et al. Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer. BMC Cancer. 2010;10:421 doi:10.1186/1471-2407-10-421.
  • Pezzotti A, Kraft P, Hankinson SE, Hunter DJ, Buring J, Cox DG. The mitochondrial A10398G polymorphism, interaction with alcohol consumption, and breast cancer risk. PLoS One. 2009;4:e5356. doi:10.1371/journal.pone.0005356.
  • Jiang H, Zhao H, Xu H, Hu L, Wang W, Wei Y, et al. Peripheral blood mitochondrial DNA content, A10398G polymorphism, and risk of breast cancer in a Han Chinese population. Cancer Sci. 2014;105:639–645. doi:10.1111/cas.12412.
  • Mitrunen K, Sillanpää P, Kataja V, Eskelinen M, Kosma VM, Benhamou S, et al. Association between manganese superoxide dismutase (MnSOD) gene polymorphism and breast cancer risk. Carcinogenesis. 2001;22:827–829. doi:10.1093/carcin/22.5.827.
  • Guo Z, Zhao S, Fan H, Du Y, Zhao Y, Wang G. Identification of sequence polymorphisms in the D-Loop region of mitochondrial DNA as a risk factor for colon cancer. Mitochondrial DNA A DNA Mapp Seq Anal. 2016;27:4244–4245. doi:10.3109/19401736.2014.1003920.
  • Kumar B, Bhat ZI, Bansal S, Saini S, Naseem A, Wahabi K, et al. Association of mitochondrial copy number variation and T16189C polymorphism with colorectal cancer in North Indian population. Tumour Biol. 2017;39:1010428317740296 doi:10.1177/1010428317740296.
  • Govatati S, Saradamma B, Malempati S, Dasi D, Thupurani MK, Nagesh N, et al. Association of mitochondrial displacement loop polymorphisms with risk of colorectal cancer in south Indian population. Mitochondrial DNA A DNA Mapp Seq Anal. 2017;28:632–637. doi:10.3109/24701394.2016.1160076.
  • Wang C, Zhao S, Du Y, Guo Z. Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA is associated with colorectal cancer outcome. Mitochondrial DNA A DNA Mapp Seq Anal. 2016;27:4361–4363. doi:10.3109/19401736.2015.1089502.
  • Theodoratou E, Din FV, Farrington SM, Cetnarskyj R, Barnetson RA, Porteous ME, et al. Association between common mtDNA variants and all-cause or colorectal cancer mortality. Carcinogenesis. 2010;31:296–301. doi:10.1093/carcin/bgp237.
  • Akouchekian M, Houshmand M, Hemati S, Ansaripour M, Shafa M. High rate of mutation in mitochondrial DNA displacement loop region in human colorectal cancer. Dis Colon Rectum. 2009;52:526–530. doi:10.1007/DCR.0b013e31819acb99.
  • Stoehlmacher J, Ingles SA, Park DJ, Zhang W, Lenz HJ. The -9Ala/-9Val polymorphism in the mitochondrial targeting sequence of the manganese superoxide dismutase gene (MnSOD) is associated with age among Hispanics with colorectal carcinoma. Oncol Rep. 2002;9:235–238. doi:10.3892/or.9.2.235.
  • Thyagarajan B, Guan W, Fedirko V, Barcelo H, Ramasubramaian R, Gross M, et al. Associations of mitochondrial polymorphisms with sporadic colorectal adenoma. Mol Carcinog. 2018;57:598–605. doi:10.1002/mc.22783.
  • Linkowska K, Jawień A, Marszałek A, Skonieczna K, Grzybowski T. Searching for association of the CAG repeat polymorphism in the mitochondrial DNA polymerase gamma gene (POLG) with colorectal cancer. Acta Biochim Pol. 2015;62:625–627. doi:10.18388/abp.2014_935.
  • Chen H, Xu L, Qi Q, Yao Y, Zhu M, Wang Y. A haplotype variation affecting the mitochondrial transportation of hMYH protein could be a risk factor for colorectal cancer in Chinese. BMC Cancer. 2008;8:269doi:10.1186/1471-2407-8-269.Choi SJ, Kim SH, Kang HY, Lee J, Bhak JH, Sohn I, et al. Mutational hotspots in the mitochondrial genome of lung cancer. Biochem Biophys Res Commun. 2011;407:23–27. doi:10.1016/j.bbrc.2011.02.078.
  • Tanaka T, Kobunai T, Yamamoto Y, Murono K, Otani K, Yasuda K, et al. Increased copy number variation of mtDNA in an array-based digital PCR assay predicts ulcerative colitis-associated colorectal cancer. In Vivo. 2017;31:713–718.
  • Thyagarajan B, Guan W, Fedirko V, Barcelo H, Tu H, Gross M, et al. No association between mitochondrial DNA copy number and colorectal adenomas. Mol Carcinog. 2016;55:1290–1296. doi:10.1002/mc.22370.
  • Govatati S, Malempati S, Saradamma B, Divyamaanasa D, Naidu BP, Bramhachari PV, et al. Manganese-superoxide dismutase (Mn-SOD) overexpression is a common event in colorectal cancers with mitochondrial microsatellite instability. Tumour Biol. 2016;37:10357–10364. doi:10.1007/s13277-016-4918-0.
  • Legras A, Lièvre A, Bonaiti-Pellié C, Cottet V, Pariente A, Nalet B, et al. Mitochondrial D310 mutations in colorectal adenomas: an early but not causative genetic event during colorectal carcinogenesis. Int J Cancer. 2008;122:2242–2248. doi:10.1002/ijc.23370.
  • Huang B, Gao YT, Shu XO, Wen W, Yang G, Li G, et al. Association of leukocyte mitochondrial DNA copy number with colorectal cancer risk: results from the Shanghai Women's Health Study. Cancer Epidemiol Biomarkers Prev. 2014;23:2357–2365. doi:10.1158/1055-9965.EPI-14-0297.
  • Williams SB, Ye Y, Huang M, Chang DW, Kamat AM, Pu X, et al. Mitochondrial DNA content as risk factor for bladder cancer and its association with mitochondrial DNA polymorphisms. Cancer Prev Res (Phila). 2015;8:607–613. doi:10.1158/1940-6207.CAPR-14-0414.
  • Moore A, Lan Q, Hofmann JN, Liu CS, Cheng WL, Lin TT, et al. A prospective study of mitochondrial DNA copy number and the risk of prostate cancer. Cancer Causes Control. 2017;28:529–538. doi:10.1007/s10552-017-0879-x.
  • Tu H, Gu J, Meng QH, Kim J, Davis JW, He Y, et al. Mitochondrial DNA copy number in peripheral blood leukocytes and the aggressiveness of localized prostate cancer. Oncotarget. 2015;6:41988–41996. doi:10.18632/oncotarget.5889.
  • Giorgi EE, Li Y, Caberto CP, Beckman KB, Lum-Jones A, Haiman CA, et al. No association between the mitochondrial genome and prostate cancer risk: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev. 2016;25:1001–1003. doi:10.1158/1055-9965.EPI-16-0111.
  • Cooper ML, Adami HO, Grönberg H, Wiklund F, Green FR, Rayman MP. Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk. Cancer Res. 2008;68:10171–10177. doi:10.1158/0008-5472.CAN-08-1827.
  • Granados JB, Méndez JP, Feria-Bernal G, García-García E, Tejeda ME, Rojano-Mejía D, et al. Association of a TFAM haplotype with aggressive prostate cancer in overweight or obese Mexican Mestizo men. Urol Oncol. 2017;35:111.e9–e14. doi:10.1016/j.urolonc.2016.10.011.
  • Zhou W, Zhu M, Gui M, Huang L, Long Z, Wang L, et al. Peripheral blood mitochondrial DNA copy number is associated with prostate cancer risk and tumor burden. PLoS One. 2014;9:e109470. doi:10.1371/journal.pone.0109470.
  • Fachal L, Gómez-Caamaño A, Alvarez Iglesias V, Gómez Carballa A, Calvo P, Salas A, et al. No association between typical European mitochondrial variation and prostate cancer risk in a Spanish cohort. J Hum Genet. 2014;59:411–414. doi:10.1038/jhg.2014.46.
  • Zhang J, Li D, Qu F, Chen Y, Li G, Jiang H, et al. Association of leukocyte mitochondrial DNA content with glioma risk: evidence from a Chinese case-control study. BMC Cancer. 2014;14:680. doi:10.1186/1471-2407-14-680.
  • Shen J, Song R, Lu Z, Zhao H. Mitochondrial DNA copy number in whole blood and glioma risk: a case control study. Mol Carcinog. 2016;55:2089–2094. doi:10.1002/mc.22453.
  • Blomberg Jensen M, Leffers H, Petersen JH, Daugaard G, Skakkebaek NE, Rajpert-De Meyts E. Association of the polymorphism of the CAG repeat in the mitochondrial DNA polymerase gamma gene (POLG) with testicular germ-cell cancer. Ann Oncol. 2008;19:1910–1914. doi:10.1093/annonc/mdn407.
  • Bai Y, Guo Z, Xu J, Zhang J, Cui L, Zhang H, et al. The 9-bp deletion at position 8272 in region V of mitochondrial DNA is associated with renal cell carcinoma outcome. Mitochondrial DNA A DNA Mapp Seq Anal. 2014;27:1–1975. doi:10.3109/19401736.2014.971312.
  • Bai Y, Guo Z, Xu J, Liu S, Zhang J, Cui L, et al. Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA is associated with renal cell carcinoma outcome. Mitochondrial DNA. 2015;26:224–226. doi:10.3109/19401736.2013.825772.
  • Xu J, Guo Z, Zhang J, Cui L, Zhang S, Bai Y. Single nucleotide polymorphisms in the mitochondrial displacement loop and age-at-onset of renal cell carcinoma. Sci Rep. 2013;3:2408. doi:10.1038/srep02408.
  • Zhang J, Guo Z, Bai Y, Cui L, Zhang S, Xu J. Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for renal cell carcinoma. Biomed Rep. 2013;1:563–566. doi:10.3892/br.2013.113.
  • Elsayed ET, Hashad MM, Elgohary IE. Mitochondrial DNA copy number variation as a potential predictor of renal cell carcinoma. Int J Biol Markers. 2017;32:e313–e318. doi:10.5301/ijbm.5000268.
  • Hofmann JN, Hosgood HD, Liu CS, Chow WH, Shuch B, Cheng WL, et al. A nested case-control study of leukocyte mitochondrial DNA copy number and renal cell carcinoma in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Carcinogenesis. 2014;35:1028–1031. doi:10.1093/carcin/bgt495.
  • Luna B, Bhatia S, Yoo C, Felty Q, Sandberg DI, Duchowny M, et al. Proteomic and mitochondrial genomic analyses of pediatric brain tumors. Mol Neurobiol. 2015;52:1341–1363. doi:10.1007/s12035-014-8930-3.
  • Kim C, Bassig BA, Seow WJ, Hu W, Purdue MP, Huang WY, et al. Mitochondrial DNA copy number and chronic lymphocytic leukemia/small lymphocytic lymphoma risk in two prospective studies. Cancer Epidemiol Biomarkers Prev. 2015;24:148–153. doi:10.1158/1055-9965.EPI-14-0753.
  • Hosnijeh FS, Lan Q, Rothman N, San Liu C, Cheng WL, Nieters A, et al. Mitochondrial DNA copy number and future risk of B-cell lymphoma in a nested case-control study in the prospective EPIC cohort. Blood. 2014;124:530–535. doi:10.1182/blood-2013-10-532085.
  • Yacoub HA, Mahmoud WM, El-Baz HA, Eid OM, ELfayoumi RI, Elhamidy SM, et al. Novel mutations in the displacement loop of mitochondrial DNA are associated with acute lymphoblastic leukemia: a genetic sequencing study. Asian Pac J Cancer Prev. 2014;15:9283–9289. doi:10.7314/apjcp.2014.15.21.9283.
  • Datta S, Ray A, Singh R, Mondal P, Basu A, De Sarkar N, et al. Sequence and expression variations in 23 genes involved in mitochondrial and non-mitochondrial apoptotic pathways and risk of oral leukoplakia and cancer. Mitochondrion. 2015;25:28–33. doi:10.1016/j.mito.2015.09.001.
  • Datta S, Majumder M, Biswas NK, Sikdar N, Roy B. Increased risk of oral cancer in relation to common Indian mitochondrial polymorphisms and Autosomal GSTP1 locus. Cancer. 2007;110:1991–1999. doi:10.1002/cncr.23016.
  • Mondal R, Ghosh SK. Accumulation of mutations over the complete mitochondrial genome in tobacco-related oral cancer from northeast India. Mitochondrial DNA. 2013;24:432–439. doi:10.3109/19401736.2012.760551.
  • Mondal R, Ghosh SK, Talukdar FR, Laskar RS. Association of mitochondrial D-loop mutations with GSTM1 and GSTT1 polymorphisms in oral carcinoma: a case control study from northeast India. Oral Oncol. 2013;49:345–353. doi:10.1016/j.oraloncology.2012.11.003.
  • Mondal R, Ghosh SK, Choudhury JH, Seram A, Sinha K, Hussain M, et al. Mitochondrial DNA copy number and risk of oral cancer: a report from Northeast India. PLoS One. 2013;8:e57771. doi:10.1371/journal.pone.0057771.
  • Pandey R, Mehrotra D, Catapano C, Choubey V, Sarin R, Mahdi AA, et al. Association of mitochondrial deoxyribonucleic acid mutation with polymorphism in CYP2E1 gene in oral carcinogenesis. J Oral Biol Craniofac Res. 2012;2:4–9. doi:10.1016/S2212-4268(12)60003-7.
  • He Y, Gong Y, Gu J, Lee JJ, Lippman SM, Wu X. Increased leukocyte mitochondrial DNA copy number is associated with oral premalignant lesions: an epidemiology study. Carcinogenesis. 2014;35:1760–1764. doi:10.1093/carcin/bgu093.
  • Liu Y, Zha L, Li B, Zhang L, Yu T, Li L. Correlation between superoxide dismutase 1 and 2 polymorphisms and susceptibility to oral squamous cell carcinoma. Exp Ther Med. 2014;7:171–178. doi:10.3892/etm.2013.1375.
  • Guo Y, Cai Q, Samuels DC, Ye F, Long J, Li CI, et al. The use of next generation sequencing technology to study the effect of radiation therapy on mitochondrial DNA mutation. Mutat Res. 2012;744:154–160. doi:10.1016/j.mrgentox.2012.02.006.
  • Peng Z, Xie C, Wan Q, Zhang L, Li W, Wu S. Sequence variations of mitochondrial DNA D-loop region are associated with familial nasopharyngeal carcinoma. Mitochondrion. 2011;11:327–333. doi:10.1016/j.mito.2010.12.008.
  • Ghosh SK, Singh AS, Mondal R, Kapfo W, Khamo V, Singh YI. Dysfunction of mitochondria due to environmental carcinogens in nasopharyngeal carcinoma in the ethnic group of Northeast Indian population. Tumor Biol. 2014;35:6715–6724. doi:10.1007/s13277-014-1897-x.
  • Choi SJ, Kim SH, Kang HY, Lee J, Bhak JH, Sohn I, Jung SH, et al. Mutational hotspots in the mitochondrial genome of lung cancer. Biochem Biophys Res Commun. 2011;407:23–27. doi:10.1016/j.bbrc.2011.02.078.
  • Ding C, Li R, Wang P, Jin P, Li S, Guo Z. Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as a risk factor for lung cancer. Mitochondrial DNA. 2012;23:251–254. doi:10.3109/19401736.2012.674120.
  • Meng S, De Vivo I, Liang L, Hu Z, Christiani DC, Giovannucci E, et al. Pre-diagnostic leukocyte mitochondrial DNA copy number and risk of lung cancer. Oncotarget. 2016;7:27307–27312. doi:10.18632/oncotarget.8426.
  • Kim C, Bassig BA, Seow WJ, Hu W, Purdue MP, Shu XO, et al. Pooled analysis of mitochondrial DNA copy number and lung cancer risk in three prospective studies. Cancer Epidemiol Biomarkers Prev. 2014;23:2977–2980. doi:10.1158/1055-9965.EPI-14-1070.
  • Hu WX, Ding CM, Li RJ, Fan HY, Guo ZJ, Liu W. Single nucleotide polymorphisms in the mitochondrial displacement loop and age-at-onset of non-small cell lung cancer. Genet Mol Res. 2015;14:2512–2517. doi:10.4238/2015.March.30.9.
  • Xun J, Song X, Gao S, Yang H, Li Z, Li L. Identification of sequence polymorphisms in the D-loop region of mitochondrial DNA as risk biomarker for liposarcoma. Mitochondrial DNA A DNA Mapp Seq Anal. 2016;27:3403–3404. doi:10.3109/19401736.2015.1018240.
  • Moradi MT, Yari K, Rahimi Z, Kazemi E, Shahbazi M. Manganese superoxide dismutase (MnSOD Val-9Ala) gene polymorphism and susceptibility to gastric cancer. Asian Pac J Cancer Prev. 2015;16:485–488. doi:10.7314/apjcp.2015.16.2.485.
  • Wu H, Gu YH, Wei L, Guo TK, Zhao Y, Su G, et al. Association of Romo1 gene genetic polymorphisms with risk of gastric cancer in northwestern Chinese population. Pathol Oncol Res. 2015;21:581–587. doi:10.1007/s12253-014-9858-7.
  • Wang C, Wang Y, Wang H, Zhang R, Guo Z. Mitochondrial DNA haplogroup N is associated good outcome of gastric cancer. Tumour Biol. 2014;35:12555–12559. doi:10.1007/s13277-014-2575-8.
  • Wang H, Wang Y, Zhao Q, Guo Z, Zhang F, Zhao Y, Zhang R. Identification of sequence polymorphisms in the D-Loop region of mitochondrial DNA as a risk factor for gastric cancer. Mitochondrial DNA A DNA Mapp Seq Anal. 2016;27:1045–1047. doi:10.3109/19401736.2014.926546.
  • Er LM, Li Y, Er L, Wu M, Zheng XL, Guo ZJ, et al. Associations between single nucleotide polymorphisms in the mitochondrial DNA D-loop region and outcome of gastroenteropancreatic neuroendocrine neoplasm. Ann Clin Lab Sci. 2018;48:333–337.
  • Er LM, Wu ML, Gao Y, Wang SJ, Li Y. Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for astroenteropancreatic neuroendocrine neoplasm. J Clin Lab Anal. 2017;31:e22078. doi:10.1002/jcla.22078.
  • Wei L, Zhao Y, Guo TK, Li PQ, Wu H, Xie HB, et al. Association of mtDNA D-loop polymorphisms with risk of gastric cancer in Chinese population. Pathol Oncol Res. 2011;17:735–742. doi:10.1007/s12253-011-9378-7.
  • Martin RC, Lan Q, Hughes K, Doll MA, Martini BD, Lissowska J, et al. No apparent association between genetic polymorphisms (-102 C > T) and (-9 T > C) in the human manganese superoxide dismutase gene and gastric cancer. J Surg Res. 2005;124:92–97. doi:10.1016/j.jss.2004.09.009.
  • Jin EH, Sung JK, Lee SI, Hong JH. Mitochondrial NADH dehydrogenase subunit 3 (MTND3) polymorphisms are associated with gastric cancer susceptibility. Int J Med Sci. 2018;15:1329–1333. doi:10.7150/ijms.26881.
  • Liao LM, Baccarelli A, Shu XO, Gao YT, Ji BT, Yang G, et al. Mitochondrial DNA copy number and risk of gastric cancer: a report from the Shanghai Women's Health Study. Cancer Epidemiol Biomarkers Prev. 2011;20:1944–1949. doi:10.1158/1055-9965.EPI-11-0379.
  • Sun Y, Gu J, Ajani JA, Chang DW, Wu X, Stroehlein JR. Genetic and intermediate phenotypic susceptibility markers of gastric cancer in Hispanic Americans: a case-control study. Cancer. 2014;120:3040–3048. doi:10.1002/cncr.28792.
  • Li Z, Deng B, Wang W, Jia Z, Liu X, Li N. Single nucleotide polymorphisms in the mitochondrial displacement loop region predict malignant melanoma outcome: a study in Chinese Han population. Mitochondrial DNA A DNA Mapp Seq Anal. 2016;27:1812–1816. doi:10.3109/19401736.2014.963824.
  • Zhang W, Wang W, Jia Z. Single nucleotide polymorphisms in the mitochondrial displacement loop region modifies malignant melanoma: a study in Chinese Han population. Mitochondrial DNA. 2015;26:205–207. doi:10.3109/19401736.2014.900613.
  • Shen J, Gopalakrishnan V, Lee JE, Fang S, Zhao H. Mitochondrial DNA copy number in peripheral blood and melanoma risk. PLoS One. 2015;10:e0131649. doi:10.1371/journal.pone.0131649.
  • Xu E, Sun W, Gu J, Chow WH, Ajani JA, Wu X. Association of mitochondrial DNA copy number in peripheral blood leukocytes with risk of esophageal adenocarcinoma. Carcinogenesis. 2013;34:2521–2524. doi:10.1093/carcin/bgt230.
  • Li XY, Guo YB, Su M, Cheng L, Lu ZH, Tian DP. Association of mitochondrial haplogroup D and risk of esophageal cancer in Taihang Mountain and Chaoshan areas in China. Mitochondrion. 2011;11:27–32. doi:10.1016/j.mito.2010.06.005.
  • Abnet CC, Huppi K, Carrera A, Armistead D, McKenney K, Hu N, et al. Control region mutations and the 'common deletion' are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinoma. BMC Cancer. 2004;4:30. doi:10.1186/1471-2407-4-30.
  • Zhang R, Wang R, Zhang F, Wu C, Fan H, Li Y, et al. Single nucleotide polymorphisms in the mitochondrial displacement loop and outcome of esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2010;29:155. doi:10.1186/1756-9966-29-155.
  • Zhai K, Chang L, Zhang Q, Liu B, Wu Y. Mitochondrial C150T polymorphism increases the risk of cervical cancer and HPV infection. Mitochondrion. 2011;11:559–563. doi:10.1016/j.mito.2011.02.005.
  • Feng D, Xu H, Li X, Wei Y, Jiang H, Xu H, et al. An association analysis between mitochondrial DNA content, G10398A polymorphism, HPV infection, and the prognosis of cervical cancer in the Chinese Han population. Tumor Biol. 2016;37:5599–5607. doi:10.1007/s13277-015-4429-4.
  • Guardado-Estrada M, Medina-Martínez I, Juárez-Torres E, Roman-Bassaure E, Macías L, Alfaro A, et al. The Amerindian mtDNA haplogroup B2 enhances the risk of HPV for cervical cancer: de-regulation of mitochondrial genes may be involved. J Hum Genet. 2012;57:269–276. doi:10.1038/jhg.2012.17.
  • Attatippaholkun W, Wikainapakul K. Predominant genotypes and alleles of two functional polymorphisms in the manganese superoxide dismutase gene are not associated with Thai cervical or breast cancer. Asian Pac J Cancer Prev. 2013;14:3955–3961. doi:10.7314/APJCP.2013.14.6.3955.
  • Sun Y, Zhang L, Ho SS, Wu X, Gu J. Lower mitochondrial DNA copy number in peripheral blood leukocytes increases the risk of endometrial cancer. Mol Carcinog. 2016;55:1111–1117. doi:10.1002/mc.22373.
  • Xu L, Hu Y, Chen B, Tang W, Han X, Yu H, et al. Mitochondrial polymorphisms as risk factors for endometrial cancer in southwest China. Int J Gynecol Cancer. 2006;16:1661–1667. doi:10.1111/j.1525-1438.2006.00641.x.
  • Czarnecka AM, Klemba A, Semczuk A, Plak K, Marzec B, Krawczyk T, et al. Common mitochondrial polymorphisms as risk factor for endometrial cancer. Int Arch Med. 2009;2:33. doi:10.1186/1755-7682-2-33.
  • Liu S, Shi S, Li Y, Kong D. Identification of sequence nucleotide polymorphisms in the D-loop region of mitochondrial DNA as a risk factor for epithelial ovarian cancer. Mitochondrial DNA A DNA Mapp Seq Anal. 2016;27:9–11. doi:10.3109/19401736.2013.867435.
  • Earp MA, Brooks-Wilson A, Cook L, Le N. Inherited common variants in mitochondrial DNA and invasive serous epithelial ovarian cancer risk. BMC Res Notes. 2013;6:425. doi:10.1186/1756-0500-6-425.
  • Permuth-Wey J, Chen YA, Tsai YY, Chen Z, Qu X, Lancaster JM, et al. Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk. Cancer Epidemiol Biomarkers Prev. 2011;20:1131–1145. doi:10.1158/1055-9965.EPI-10-1224.
  • Kong D, Shi S, Li Y, Li R, Li M. Single nucleotide polymorphisms in the mitochondrial displacement loop and age-at-onset of epithelial ovarian cancer. Mitochondrial DNA A DNA Mapp Seq Anal. 2016;27:1141–1143. doi:10.3109/19401736.2014.936320.
  • Klemba A, Kowalewska M, Kukwa W, Tonska K, Szybinska A, Mossakowska M, et al. Mitochondrial genotype in vulvar carcinoma - cuckoo in the nest. J Biomed Sci. 2010; 17:73doi:10.1186/1423-0127-17-73.
  • Li S, Wan P, Peng T, Xiao K, Su M, Shang L, et al. Associations between sequence variations in the mitochondrial DNA D-loop region and outcome of hepatocellular carcinoma. Oncol Lett. 2016;11:3723–3728. doi:10.3892/ol.2016.4466.
  • Wang H, Xu J, Li D, Zhang S, Guo Z. Identification of sequence polymorphisms in the mitochondrial cytochrome c oxidase genes as risk factors for hepatocellular carcinoma. J Clin Lab Anal. 2018;32:e22299. doi:10.1002/jcla.22299.
  • Jin Y, Yu Q, Zhou D, Chen L, Huang X, Xu G, et al. The mitochondrial DNA 9-bp deletion polymorphism is a risk factor for hepatocellular carcinoma in the Chinese population. Genet Test Mol Biomarkers. 2012;16:330–334. doi:10.1089/gtmb.2011.0208.
  • Zhang R, Zhang F, Wang C, Wang S, Shiao YH, Guo Z. Identification of sequence polymorphism in the D-Loop region of mitochondrial DNA as a risk factor for hepatocellular carcinoma with distinct etiology. J Exp Clin Cancer Res. 2010;29:130. doi:10.1186/1756-9966-29-130.
  • Wang C, Zhang F, Fan H, Peng L, Zhang R, Liu S, et al. Sequence polymorphisms of mitochondrial D-loop and hepatocellular carcinoma outcome. Biochem Biophys Res Commun. 2011;406:493–496. doi:10.1016/j.bbrc.2011.02.088.
  • Hashad DI, Elyamany AS, Salem PE. Mitochondrial DNA copy number in egyptian patients with hepatitis C virus-related hepatocellular carcinoma. Genet Test Mol Biomarkers. 2015;19:604–609. doi:10.1089/gtmb.2015.0132.
  • Lynch SM, Weinstein SJ, Virtamo J, Lan Q, Liu CS, Cheng WL, et al. Mitochondrial DNA copy number and pancreatic cancer in the alpha-tocopherol beta-carotene cancer prevention study. Cancer Prev Res (Phila)). 2011;4:1912–1919. doi:10.1158/1940-6207.CAPR-11-0002.
  • Wang L, Bamlet WR, de Andrade M, Boardman LA, Cunningham JM, Thibodeau SN, et al. Mitochondrial genetic polymorphisms and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev. 2007;16:1455–1459. doi:10.1158/1055-9965.EPI-07-0119.
  • Guo W, Yang D, Xu H, Zhang Y, Huang J, Yang Z, et al. Mutations in the D-loop region and increased copy number of mitochondrial DNA in human laryngeal squamous cell carcinoma. Mol Biol Rep. 2013;40:13–20. doi:10.1007/s11033-012-1939-7.
  • Bussard KM, Siracusa LD. Understanding mitochondrial polymorphisms in cancer. Cancer Res. 2017;77:6051–6059. doi:10.1158/0008-5472.CAN-17-1939.
  • Vivian CJ, Brinker AE, Graw S, Koestler DC, Legendre C, Gooden GC, et al. Mitochondrial genomic backgrounds affect nuclear DNA methylation and gene expression. Cancer Res. 2017;77:6202–6214. doi:10.1158/0008-5472.CAN-17-1473.
  • Chen C, Ba Y, Li D, Du X, Lia X, Yang H, et al. Genetic variations of mitochondrial genome modify risk and prognosis of hepatocellular carcinoma patients. Clin Res Hepatol Gastroenterol. 2017;41:378–385. doi:10.1016/j.clinre.2016.12.002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.